Loss of Heterozygosity
2 clinical trials · Condition
◉ Watch Loss of Heterozygosity
| Record | Firm | Date |
|---|---|---|
| A Training Set for the HRD Model in EOC (NCT04651933) | Lei Li | 2020-11-26 |
| Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT03845296) | SWOG Cancer Research Network | 2019-04-16 |
Track Loss of Heterozygosity automatically
Every clearance here is in the API, with alerts when new ones post.